Team

A stategic thinker Manon Decelles has over 25 years of experience in the pharmaceutical industry grained in senior strategic roles in finance, marketing, strategy, business development and M&A.

In 2018, she founded pharmdside Strategic Business Advisors, a boutique advisory and consulting firm assisting pharmaceutical companies drinving growth through strategic partnerships, becoming Business development Advisor to several pharmaceutical companies C-suites.

Prior to founding Pharmdside, she managed the commercialization of a wide range of healthcare products and worked on numerous licensing agreements and acquisitions, generating hundreds of millions of dollars in deal value, at leading phrmaceutical companies including Aventis, Sanofi, Pharmascience and McKesson, a fourtune 500 company.

Manon holds a bachelor of business administration from University of Montereal, HEC and is Chartered Professional Accountant (CPA).

She is also serving as past President of the Canadian Healtcare Licensing Association (CHLA) and also serves on the board of Directors of the International Pharmaceutical licensing Society (IPLS), a group of 9 European licensing associations.

Nathalie Gosset consistently delivers above and beyond expectations: Not only is she a lawyer, she is also an accountant with a combined executive MBA from UQAM/Paris-Dauphine and is a trained Six Sigma Greenbelt. She has spent her 18-year career embedding legal and regulatory requirements into her clients’ business operations.

Nathalie started her practice in the intellectual property department of a large Canadian legal practice where she reviewed packaging and advertising campaigns as well as drafting complex license agreements. She soon realized that she wanted more practical experience and accepted an offer in the Caribbean to lead the legal department of a large telecommunications company.

When she returned to Montreal in 2006, she was hired as senior legal counsel for a toy manufacturer, reviewing complex international distribution agreements handling the relationship with the various regulators including Health Canada and Advertising Standards Canada.

For the past 9 years, Nathalie has worked in the healthcare/pharmaceutical sector for a Fortune 500 company, leading a team of over 70 professionals as Senior Director in charge of Quality, Regulatory, Pharmacovigilance, Compliance and Privacy.

Anjan has over 20 years of international biopharmaceutical experience in clinical trial management, sales, marketing, operations, strategic planning and business development.

Prior to GLyPharma, he worked at ActoGeniX (acquired by Intrexon), and Shionogi Inc., where he led the $127 Million acquisition of Victory Pharma.

Between 2002-2010, he worked at Sanofi (Aventis) in both Canada and the United States in business development and strategic planning.

Prior to joining Aventis, he worked in sales and marketing at Abbott Canada. Anjan has extensive experience in dermatology, cardiovascular disease, diabetes and IBD among other therapeutic areas.

Anjan holds an MBA from Queen’s University (Montreal, Canada) a BSc from Concordia University (Montreal, Canada) and a MSc of Biotechnology from Johns Hopkins University (Baltimore, MD).

Jean developed a strong expertise in sales and marketing. He worked for medium- and large-size pharmaceutical companies such as GSK, Hospira and Sandoz. He worked as well as in the field of communications for agencies specializing in health care. He also has established is strategic consulting firm were he has been able to support many organisation in the development of their commercial strategy and launch plan.

With Sandoz Jean was responsible for the leadership of the marketing team and all marketing activities for a portfolio of more than 260 generic products and the launch of more than ten products per year. He was working closely with the Business Development team to identify key molecules to win market share and accelerated pipeline development.

With Hospira Jean was responsible for marketing strategy planning and business development for the Canadian and Latin America markets. His activities mainly focused on the business strategies of generic injectable products, biosimilars and medical equipment sold in hospital environments. In this capacity, he demonstrated his ability to draw up, implement and follow up on strategic plans. The quality of his work was recognized when he received the President’s Award.

His strategic approach aspires to always maintain a deep understanding of internal and external influences that could affect business activities. He is recognized for his analytical capacities and business skills. Jean also makes sure that all aspects of business operations support improvement of the capacity to appropriately serve customers.

Jean Chretien holds a Bachelor’s Degree in Commerce as well as a Master’s Degree in Business Administration.

Dr. Dan Popovici-Toma has over 25 years of experience in the pharmaceutical and biotechnology fields, hospital settings and strategic consultancy. He worked as a Medical and Scientific Advisor for companies such as Sanofi, Valeant, BioK+, covering a broad array of therapeutic areas including cardiovascular and metabolism, sleep/CNS, allergy, dermatology, oncology, infectious diseases.

Dan’s key area of expertise is the full integration of clinical development into drug life-cycle management from pre-launch, launch and LOE, capitalizing on clinical unmet medical need and developing strategic alliances with various health care stakeholders. He has an extensive clinical trials experience, from study design inception to clinical trial execution.

Dan obtained his MD from “Carol Davila” University of Medicine Bucharest, Romania and specialised in Infectious Diseases. He is also a dedicated Institutional Review Board (IRB) member.

Dr. Tibor Kapusy has over 30 years of experience in pharmaceutical companies , most recently as Director of regulatory Affairs at Bausch Health Canada. Prior to that, he worked in clinical research and medical affairs, leading teams of medical and scientific advisors at Merck, Pfizer, Novartis, Shering-Plough, Valeant Bausch Helth.

Tibor provides regulatory expertise for new drug submission (NDS), sNDS, pre-NDS meetings/negotiations with Health Canada, Product Monograph development and negotiations, RMPs, submission of Clinical Trial Application, Medical Device-License Application package.

His experience spans over regulatory and clinical product development activities for a variety of products types (orals, injectables, topicals, sterile eye drops, inhaled solutions/aerosols, medical devices, etc.) for prescription drugs and DIN-OTCs; within multiple therapeutic fields such as cardiovascular and metabolic diseases, respiratory disease, CNS, pain management, rheumatology, anti-inflammatory, anti-Infectives, dermatological, ophthalmologic and various rare/orphan diseases.

For the last 18 years, Tibor has provided scientific expertise on business development activities such as scientific review, due diligence and proposed regulatory strategy for product acquisition, in-licensing, joint-venture, partnerships.

Tibor obtained his MD from the University of medicine and pharmacy of Tirgu-Mures, Romania and his Diploma in Management Studies from the Buckinghamshire University Collegue (United Kingdom), The Buckinghamshire Business School.